[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351132-105":59,"doc-detail-351132-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","antigen-specific-ganglioside-serological-profile-of-pancreatic-and-gastric-cancer-patients","Antigen-Specific Ganglioside Serological Profile of Pancreatic and Gastric Cancer Patients","","Background: Altered glycosphingolipidome in cancer tissues and cells mirrors circulating glycosphingolipid (GSL) profiles, supporting cancer biomarker development and immune-related mechanism discovery. Methods: A microscale GSL extraction was combined with multiple overlay TLC assays and IR-MALDI-o-TOF MS for first-time serum analysis of CD75s-, CD15s-, and iso-CD75s-containing sialylated GSLs across ganglio- and neolacto-series. Results: The antigen-specific workflow identified 80 sialylated antigen-containing GSLs in human sera and discriminated gastric and pancreatic cancer types, showing a tumor stage-linked decrease in complex fucosylated neolacto-gangliosides. Conclusions: The observed drop suggests an early-stage role for these polar gangliosides in evading humoral tumor immune responses.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/antigen-specific-ganglioside-serological-profile-of-pancreatic-and-gastric-cancer-patients/351132/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/antigen-specific-ganglioside-serological-profile-of-pancreatic-and-gastric-cancer-patients/351132.png","ImageObject",300,407,{"name":92,"@type":93},"Rowan","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What antigens were targeted in the serum analysis?","Question",{"text":112,"@type":113},"The study focused on serological CD75s, CD15s, and iso-CD75s antigens in sialylated glycosphingolipids across ganglio- and neolacto-series.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the antigen-specific GSL workflow performed?",{"text":117,"@type":113},"It combined microscale GSL extraction with multiple overlay TLC assays and IR-MALDI-o-TOF MS to profile specific antigen-containing glycolipids from serum.",{"name":119,"@type":110,"acceptedAnswer":120},"How did the GSL profiles differ between pancreatic and gastric cancer?",{"text":121,"@type":113},"Differential semi-quantitative analysis indicated a tumor type-specific GSL profile, while both cancer types showed a drop in complex fucosylated neolacto-gangliosides during tumor progression.",{"name":123,"@type":110,"acceptedAnswer":124},"What does the decreased complex fucosylated neolacto-gangliosides suggest?",{"text":125,"@type":113},"The decrease implies a role for highly polar complex ganglioside species in evading humoral tumor immune responses in early tumor stages.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},351132,1790198326,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":143,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":149,"preview_page_count":19,"preview_urls":150},1099514067415,"https://ap-avatar.wpscdn.com/avatar/100002539d78ffe74a7?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779092875211072502","Article  \nAntigen-Specific Ganglioside Serological Profile of Pancreatic and Gastric Cancer Patients by Multiple TLC Overlay Assay and IR-MALDI Mass Spectrometry  \nJamal Souady 1,2, Stephan Kirsch 2, Marcel Hülsewig 2, Romana Masnikosa 3, Huong Giang Vo 4, Jasna Peter-Katalini´c 2,5 and Laura Bindila 4, *  \nAcademic Editor: Alain P. Gobert  \nReceived: 28 November 2025  \nRevised: 4 February 2026  \nAccepted: 9 February 2026  \nPublished: 18 February 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 QIAGEN GmbH, 40724 Hilden, Germany  \n2 Institute of Medical Physics and Biophysics, University of Münster, D-48149 Münster, Germany  \n3 Department of Physical Chemistry, Institute of Nuclear Sciences Vinca, University of Belgrade, Mike Petrovica Alasa 12-14, 11000 Belgrade, Serbia; [romana@vin.bg.ac.rs](romana@vin.bg.ac.rs)  \n4 Clinical Lipidomics Unit, Institute of Physiological Chemistry, University Medical Center Mainz, D-55128 Mainz, Germany  \n5 Department of Biotechnology, University of Rijeka, 51000 Rijeka, Croatia  \n* Correspondence: bindila@uni-mainz.de; Tel.: +49-61313925794; Fax: +49-61313923536  \nSimple Summary  \nThe serological CD75s, CD15s, and iso-CD75s antigens in glycolipids play a significant role in pancreatic and gastric cancer and also differentiate the two cancer types. We evidenced that in both cancers, these antigens are preferentially and significantly expressed on long-chain neolacto-species, pointing toward specific glycosylation processing in immune evasion in these cancer types. The new findings of this study are enabled by the technology we developed here for serological antigen glycolipid profiling, which combines efficient micro-extraction of long-chain sialylated glycolipids with overlay antibody/lectin thin-layer chromatography staining and on-plate matrix-assisted laser desorption mass spectrometry analysis of specific antigen-containing glycolipids. This technology enabled us to explore, for the first time in cancer sera, the long-chain sialylated glycolipids of neolacto-series, which are primarily involved in peripheral immunity, along with ganglioseries, while also robustly exploring and differentiating pancreatic cancer and gastric cancer, including the different developmental stages, in a cohort of patient samples.  \nAbstract  \nBackground: Altered glycosphingolipidome in cancerous tissues and cells reflects the circulatory glycosphingolipid (GSL) profiles, which is advantageous for establishing cancer biomarkers and/or unravelling GSL-associated mechanisms of immunity in cancer. Methods: Here, we combined a microscale extraction of GSLs with multiple overlay TLC assays and IR-MALDI-o-TOF MS and implemented it for the first time in serum analysis of CD75s-, CD15s-, and iso-CD75s-containing sialylated GSLs of ganglio-and neolacto-series. Results: This sensitive antigen-specific targeted GSL workflow enabled the identification of 80 sialylated GSLs containing the specific antigens in human sera and was applied for the investigation of clinical serum samples from gastric/stomach cancer patients (n = 40), pancreatic cancer patients (n = 40), and a cancer-free control group (n = 20) . The CD75s-, CD15s-, and iso-CD75s-containing GSL series encompassing complex monosialylated and fucosylated GSLs of neolacto-series, with up to pentadecasaccharide chains, were detected in both cancer types, while differential semi-quantitative analysis indicates a tumor typespecific associated GSL profile. Both cancer types share a drop in the complex fucosylated  \nneolacto-gangliosides during tumor progression, implying a decreased synthesis of longchain neolacto-series. Conclusions: This drop suggesting a role of these highly polar complex ganglioside species in evading humoral tumor immune response in the early tumor stages.  \nKeywords: cancer glycolipids; ","cbCaiiCdqJVEudLH","https://ap.wps.com/l/cbCaiiCdqJVEudLH","pdf",3563835,26,"English","# Abstract\n# 1. Introduction\n## Pancreatic cancer burden and diagnosis challenges\n## Gastric cancer burden and age-related trends\n## Need for early detection biomarkers\n## Glycosphingolipid (GSL) background","[{\"question\":\"What antigens were targeted in the serum analysis?\",\"answer\":\"The study focused on serological CD75s, CD15s, and iso-CD75s antigens in sialylated glycosphingolipids across ganglio- and neolacto-series.\"},{\"question\":\"How was the antigen-specific GSL workflow performed?\",\"answer\":\"It combined microscale GSL extraction with multiple overlay TLC assays and IR-MALDI-o-TOF MS to profile specific antigen-containing glycolipids from serum.\"},{\"question\":\"How did the GSL profiles differ between pancreatic and gastric cancer?\",\"answer\":\"Differential semi-quantitative analysis indicated a tumor type-specific GSL profile, while both cancer types showed a drop in complex fucosylated neolacto-gangliosides during tumor progression.\"},{\"question\":\"What does the decreased complex fucosylated neolacto-gangliosides suggest?\",\"answer\":\"The decrease implies a role for highly polar complex ganglioside species in evading humoral tumor immune responses in early tumor stages.\"}]","Antigen-Specific Ganglioside Serological Profile of Pancreatic and Gastric Cancer Patients | PDF",1790092779,66,[151,155,159,163],{"page_no":8,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/406506442ccee2fd35cf1b8b5173ab52.webp",983,1390,{"page_no":14,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3e576a7b01135608cc8c4005cfb1c0ad.webp",982,1388,{"page_no":81,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d33695c654a4e17d39affa89ab97d6f3.webp",981,1387,{"page_no":19,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bf64c0d4c434999a05933c6111eaef13.webp",980,1385]